McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

McKesson Ventures Announces Expansion Into Growth Equity and Welcomes Peter Lafer as Head of Growth Investing

by McKesson Ventures | Oct 16, 2025 | Media Coverage

In this newly created role, Peter will focus on building and leading a dedicated effort on investments in high-growth and profitable businesses. “We are thrilled to welcome Peter to the McKesson Ventures team,” said Dave Schulte, President of McKesson Ventures. “We...

Dave Schulte Named as One of GrowthCap’s Top 25 Healthcare Investors of 2024

by McKesson Ventures | May 1, 2024 | Media Coverage

On May 1, 2024, growth investor and executive insights company GrowthCap named McKesson Ventures’ Managing Director Dave Schulte as one of its Top 25 Healthcare Investors of 2024. The list, published annually and founded in 2021, seeks to acknowledge individuals who...

McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors

by McKesson Ventures | Jun 15, 2023 | Press Releases

McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are...

McKesson Appoints Tom Rodgers to Executive Vice President & Chief of Strategy and Business Development Officer

by McKesson Ventures | Jun 5, 2020 | Press Releases

McKesson Corporation announced that Tom Rodgers has been appointed executive vice president and chief strategy and business development officer, effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team....
Personalized Medicine? We Still Have a Long Way to Go

Personalized Medicine? We Still Have a Long Way to Go

by McKesson Ventures | Mar 29, 2017 | Media Coverage

Near the end of Vator Splash Health, Wellness and Wearables, a group of venture capitalists took to the stage to discuss which healthtech trends VCs are embracing and which are overhyped. Participants included moderator Patrick Chung of Xfund and panelists Rebecca...

Recent Posts

  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
  • Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
  • Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Atropos Health Launches the Atropos Evidence™ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking

Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support

Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow